Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 The Combined Approach to Lysis Utilizing Eptifibatide and Rt-PA in Acute Ischemic Stroke-Full Dose Regimen(CLEAR-FDR)

NCT01977456 is registered in ClinicalTrials.gov with Arthur Pancioli as lead sponsor.

NCT NCT01977456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01977456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 The Combined Approach to Lysis Utilizing Eptifibatide and Rt-PA in Acute Ischemic Stroke-Full Dose Regimen(CLEAR-FDR)
Lead sponsor
Arthur Pancioli
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2013
Completion date
April 30, 2015
Enrollment
27 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

brain infarction, stroke